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Available online 9 July 2009Heterozygous mutations of the human FOXP2 gene cause a developmental disorder
involving impaired learning and production of fluent spoken language. Previous
investigations of its aetiology have focused on disturbed function of neural circuits
involved in motor control. However, Foxp2 expression has been found in the cochlea and
auditory brain centers and deficits in auditory processing could contribute to difficulties in
speech learning and production. Here, we recorded auditory brainstem responses (ABR) to
assess two heterozygous mouse models carrying distinct Foxp2 point mutations matching
those found in humans with FOXP2-related speech/language impairment. Mice which carry
a Foxp2-S321X nonsense mutation, yielding reduced dosage of Foxp2 protein, did not show
systematic ABR differences from wildtype littermates. Given that speech/language
disorders are observed in heterozygous humans with similar nonsense mutations (FOXP2-
R328X), our findings suggest that auditory processing deficits up to the midbrain level are
not causative for FOXP2-related language impairments. Interestingly, however, mice
harboring a Foxp2-R552H missense mutation displayed systematic alterations in ABR
waves with longer latencies (significant for waves I, III, IV) and smaller amplitudes
(significant for waves I, IV) suggesting that either the synchrony of synaptic transmission in
the cochlea and in auditory brainstem centers is affected, or fewer auditory nerve fibers and
fewer neurons in auditory brainstem centers are activated compared to wildtypes.
Therefore, the R552H mutation uncovers possible roles for Foxp2 in the development and/
or function of the auditory system. Since ABR audiometry is easily accessible in humans, our
data call for systematic testing of auditory functions in humans with FOXP2 mutations.






Heterozygous mutations of the FOXP2 gene cause the best
described example of an inherited speech and language
disorder in humans (Lai et al., 2001; MacDermot et al., 2005)..
(G. Ehret).
ponse; ENU, N-ethyl-N-n
er B.V. All rights reservedIt is characterized by impaired learning/production of com-
plex oral movements underlying speech, accompanied by
linguistic deficits which affect both spoken and written
modalities (Watkins et al., 2002; see Fisher, 2006 for review).
FOXP2 encodes a forkhead-box transcription factor with aitrosourea; Foxp2, forkhead-box p2; SPL, sound pressure level; WT,
.
Fig. 1 – Examples of mean ABR recordings of R552H
and S321X heterozygotes in comparison with their WT
littermates. All recordings shown were obtained with a
standard stimulus of 16 kHz tone bursts at 20 dB above
response threshold. Recordings start with sound arrival at
the ear (0 ms). Roman numbers indicate peaks I to V of the
ABR waves.
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expression of many downstream target genes (Vernes et al.,
2007). The gene is found in highly similar form in many
vertebrate species, including rodents, where it is expressed in
corresponding neuronal subpopulations of the brain (Fisher
and Scharff, 2009). Recently, an ENU (N-ethyl-N-nitrosourea)
mutagenesis strategy enabled the generation of mouse
models carrying distinct Foxp2 point mutations (single
nucleotide changes) that match those observed in humans
with speech/language deficits (Groszer et al., 2008).
Foxp2-R552H mice recapitulate the human FOXP2-R553H
missense mutation found in a particularly well-studied three-
generation family, known as the KE family; this yields an
amino-acid substitution in the encoded protein, replacing an
arginine residue with a histidine at one crucial site within the
DNA-binding domain (Lai et al., 2001). In cell-based studies,
the mutated protein shows abnormal intracellular localiza-
tion, impaired DNA-binding and disturbed regulation of
transcriptional activity of targets (Vernes et al., 2006). Foxp2-
S321Xmice carry a different type of point mutation, known as
a nonsense mutation, which creates a premature stop codon
midway through the gene, and is thus expected to encode a
truncated protein lacking the DNA-binding domain and other
key functional regions. In fact, in vivo analyses indicate that
this allele does not produce Foxp2 protein at all, most likely
due to a combination of nonsense-mediated RNA decay
(degradation of mRNA transcripts carrying the nonsense
mutation) and instability of any truncated protein that does
get produced (Groszer et al., 2008; Vernes et al., 2006). The
Foxp2-S321X mutation is very similar to a human FOXP2-
R328X nonsensemutation found in all three affectedmembers
of another family segregating speech and language deficits
(MacDermot et al. 2005).
Mice that are homozygous for the above mutations display
severe reductions in cerebellar growth and postnatal weight
gain, as well as profound general motor impairment, and die
after 3–4 weeks. Heterozygous mice are fully viable and gain
weight normally, but show deficits in motor-skill learning and
synaptic plasticity, including a lack of long-term depression in
the dorsolateral striatum (Groszer et al., 2008). Both hetero-
zygous and homozygous pups produce innate ultrasonic
vocalizations despite Foxp2 disruption (Groszer et al., 2008).
Speech learning and production make heavy demands on
rapid and fine motor control, but also depend on sensory
processingwithin the auditory system (Fitch et al., 1997; Smith
and Spirou, 2002). Thus, deficits in such sensory pathways
could potentially contribute to impaired speech and language
development (Hill et al., 2005). People carrying FOXP2 muta-
tions have been reported to have overtly normal hearing
(Hurst et al., 1990). However, to our knowledge, no formal
quantitative assessments of auditory abilities have yet been
carried out, either in humans with FOXP2-related speech/
language disorder, or in Foxp2 mutant mice. Therefore, we
used auditory brainstem response (ABR) audiometry which
employs scalp electrodes to record sound-evoked bioelectrical
potentials and to assess the peripheral auditory function of
heterozygous Foxp2 mutant mice in comparison to wildtype
(WT) littermates. The ABR method has widely been applied to
identify hearing deficits related to the auditory pathway from
the cochlea up to the auditory midbrain in mice of variousgenetic backgrounds (e.g. Shvarev, 1994; Willott et al., 1995;
Trune et al., 1996; Reimer et al., 1996; Zheng et al., 1999;
Burkard et al., 2001). Five peaks in the ABRwaves are expected.
In the mouse, peak I is suggested to refer to cochlear proces-
sing, peak II to processing in the cochlear nucleus complex,
peak III in the complex of the superior olive, peak IV in the
lateral lemniscus and peak V in the colliculus inferior.
In this context, physiological investigations of mouse
models with Foxp2 point mutations matching those that
cause human speech/language impairment provide a valuable
opportunity to identify novel aspects of aetiology in this
disorder, and shed new light on functions of the gene.
Furthermore since ABRmeasurements can easily be employed
in humans, this method is useful for model validation and
cross species comparisons.2. Results
The analyses of hearing sensitivity (ABR thresholds), and
amplitudes and latencies of the five peaks of the ABR waves
identified differences in sound processing in the auditory
periphery and brainstem of the Foxp2 mutant mice. In Fig. 1
examples of the mean ABR of R552H and S321X heterozygous
mutants and corresponding WT littermates are shown in
response to 16 kHz tone bursts at a sound pressure level set to
20 dB above threshold. Five response peaks (I–V) with different
latencies could be identified for all mice tested. No obvious
Fig. 2 – Mean ABR response thresholds. Data with standard
deviations (shown only unilaterally for clearness) from
heterozygotes and their WT littermates are plotted as a
function of the tone frequency. Statistical significance by
means of Student's two-tailed t-test is indicated by asterisk
(*P<0.05, **P<0.01).
Fig. 4 – Mean difference (heterozygote minus wildtype) of
ABR peak amplitudes averaged across all stimulation
frequencies. Statistical significance by means of one sample
t-test is indicated by asterisk (*P<0.05, **P<0.01).
32 B R A I N R E S E A R C H 1 2 8 9 ( 2 0 0 9 ) 3 0 – 3 6differences were seen in the wave patterns between S321X
heterozygotes and WT littermates (Fig. 1, bottom). There was,
however, a difference visible between the wave pattern in
R552H heterozygotes compared to their WT littermates (Fig. 1,
top). Peaks I and IV had smaller amplitudes and longer
latencies in the mutants.
Fig. 2 illustrates ABR thresholds for all four groups of
animals. The thresholds measured in the R552H heterozy-
gotes were significantly lower in the high-frequency range
(16–45.25 kHz; P<0.05 or P<0.01) indicating increased sensitivity
compared to those of their WT littermates. There was also aFig. 3 – Mean amplitudes of ABR peaks I to V for all animal
groups. Each peak amplitude corresponds to the average
value of measurements obtained with a stimulus frequency
of 16 kHz and sound pressure level 20 dB above threshold.
Error bars show standard deviations. Statistical significance
by means of Student's two-tailed t-test is indicated by
asterisk (**P<0.01).small but significant (P<0.05) opposite difference at 5.66 kHz. In
contrast, S321X heterozygotes had significantly higher thres-
holds indicating reduced sensitivity compared to their WT
littermates at 8, 32, and 45.25 kHz (P<0.05 or P<0.01).
Closer examination of the peak amplitudes (Fig. 3) at 16 kHz
tone bursts, the frequency range in which house mice are
most sensitive (Ehret, 1979; Reimer et al., 1996), and a sound
pressure level of 20 dB above threshold revealed statistically
significant differences for peaks I and IV in the R552H group.
Heterozygotes showed significantly smaller peak-to-trough
amplitudes compared to WT animals for peaks I and IV
(P<0.01). In the S321X group, peak amplitudes at 16 kHz did
not differ significantly for any peak between WT animals and
heterozygotes.
In order to include all the test frequencies in a comparison
between heterozygotes and WT animals, we calculated the
average ABR amplitude at each test frequency separately for
each peak and for all four experimental groups of animals.
Thenwe calculated the difference between these average peak
amplitudes from the heterozygotes and their respective WT
littermates (heterozygote minus WT) and averaged these
differences over all test frequencies separately for each peak.
The results as shown in Fig. 4 indicate whether there are
differences between heterozygotes and their WT littermates
in the processing of tones of any frequency in the auditory
brainstem centers related to the peaks of the ABR waves. A
significantly smaller amplitude (P<0.01) is obvious for peaks IFig. 5 –Mean latencies and standard deviations of ABR peaks
I to V for all animal groups. Each peak latency corresponds to
the average value ofmeasurements obtainedwith a stimulus
frequency of 16 kHz and sound pressure level 20 dB above
threshold. Statistical significance by means of Student's
two-tailed t-test is indicated by asterisk (**P<0.01).
Fig. 6 – Mean difference (heterozygote minus wildtype)
of ABR peak latencies averaged across all stimulation
frequencies. Statistical significance by means of one sample
t-test is indicated by asterisk (*P<0.05, **P<0.01, ***P<0.001).
33B R A I N R E S E A R C H 1 2 8 9 ( 2 0 0 9 ) 3 0 – 3 6and IV of the R552H heterozygotes (the average differences are
negative). In addition, the amplitudes of peaks IV and V
differed between S321X heterozygotes and WT littermates
(P<0.05 or P<0.01).
Besides these changes in ABR peak amplitude we also
found statistically significant differences in the latencies of
the peaks. Fig. 5 shows latency data relative to stimulus onset
obtained after stimulation with tone bursts of 16 kHz at 20 dB
above response threshold. R552H heterozygotes had signifi-
cantly longer latencies (P<0.01) compared to their WT
littermates for peaks I and IV. In contrast, no significant
differences were found between the S321X heterozygotes and
WT animals.
Similar to Fig. 4, Fig. 6 shows for each peak the difference in
peak latencies (heterozygotes minus WT) as averaged across
all tested frequencies. A significantly longer latency is obviousFig. 7 – Comparison of mean latencies of ABR peaks I–V. Data wi
frequency at tone levels of 20 dB above threshold. In all groups,
rising tone frequency.for peak I (P<0.01), and peaks III and IV (P<0.05) of the R552H
heterozygotes (the average differences are positive). In addi-
tion, the latency of peak V is shorter (P<0.001) in S321X
heterozygotes as compared to WT littermates.
Fig. 7 shows mean latencies for peaks I–V as a function of
the tone frequency. With increasing frequency the latencies of
all peaks decreased in very similar ways, as would be expected
due to the delay of activation of cochlear hair cells as
introduced by the traveling time of the traveling wave along
basilar membrane. With increasing number of the peaks, the
averaged latencies increased by about 1 ms which equals the
synaptic delays between the respective levels of the ascending
auditory pathway. There were no systematic or significant
differences in these patterns between the groups of animals.3. Discussion
A number of studies have demonstrated the general useful-
ness of ABR measurements in mice for investigating the
genetic bases of hearing impairments (e.g. Hunter andWillott,
1987; Shvarev, 1994; Willott et al., 1995; Trune et al., 1996;
Reimer et al., 1996; Zheng et al., 1999; Zhou et al., 2006). In the
present report we assessed whether there were alterations in
auditory processing in Foxp2mouse mutants by means of ABR
measurements. Based on findings from people carrying
heterozygous FOXP2 mutations it has been hypothesized
that reduced dosage of functional FOXP2 protein in humans
leads to impaired speech and language development. To date,
two aetiological point mutations of human FOXP2 have been
reported; the FOXP2-R553H missense mutation found in theth standard deviations are plotted as a function of tone
latencies from WT and heterozygous animals decrease with
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(Lai et al., 2001), and the FOXP2-R328X nonsense mutation
observed in all three affected members of a second smaller
family (MacDermot et al. 2005). Notably, the mouse lines
investigated in our study recapitulate these distinct muta-
tions; Foxp2-R552H yields an identical amino-acid substitution
to FOXP2-R553H, while Foxp2-S321X is a truncating mutation
very close to FOXP2-R328X.
Both mutants were examined on the same genetic back-
ground, the C3H/HeN substrain. C3H strains have been demon-
strated to have no hearing deficits up to at least 14 months of
age (Ehret, 1979; Trune et al., 1996; Zheng et al., 1999). By using
WT littermates as controls for our heterozygous mutants, any
change in auditory function based on the genetic background
should have been equally expressed in heterozygotes and WT
controls. Thus, the observed differences in ABR characteristics
between WT and heterozygous animals are likely to be based
on the R552H or S321X mutation, respectively.
In general, ABR thresholds from previousmeasurements in
mice were comparable to the data presented in our study
(Zheng et al., 1999; Parham et al., 2001). Trune et al. (1996)
reported similar thresholds for frequencies of 16 kHz and
above in two substrains of C3H mice. Only for frequencies of
8 kHz and below they found elevated thresholds compared to
thosemeasured in the present study, whichmay be due to the
different substrain of the mice used here.
Our study did not find evidence of gross hearing impair-
ment in either Foxp2-S321X or Foxp2-R552H heterozygotes, but
did uncover a number of significant alterations in auditory
processing, with some intriguing differences between the
distinct mutant lines. In the R552H heterozygotes, high-
frequency hearing (16 kHz and higher, Fig. 2) was up to 12 dB
better compared to WT animals. The high-frequency sensi-
tivity (above the frequencies of best hearing) in mammals is
determined mainly by the moment of inertia and frictional
losses of the osseous chain of the middle ear and by the
anatomy of the cochlea near its base (e.g. Dallos, 1973;
Eldredge, 1974; Henson, 1974). One potential explanation of
these data might be improved middle ear transmission for
high frequencies due to smaller and stiffermiddle ear ossicles,
and/or a more efficient energy transfer to the cochlear hair
cells in the high-frequency range due to anatomical diffe-
rences in the cochlea. However, a contrasting pattern of re-
sults was seen for the S321X heterozygotes, which displayed
decreased sensitivity in the high-frequency range, perhaps
reflecting a reduced middle ear transmission for high fre-
quencies and/or a less efficient energy transfer to the cochlear
hair cells in the high-frequency range.
Although the ear is not noted as one of the major sites of
Foxp2 expression, in-situ hybridization studies of mouse
embryos at embryonic day 13.5 have detected Foxp2 mRNA in
single cells of the developing inner ear (Gray et al., 2004; Mouse
Genome Informatics Accession ID: 3507431). FOXP2 expression
has also been documented in subtracted cDNA libraries
prepared from developing human cochlea at 16–22 weeks of
gestation (NCBI dbEST ID: 12768; Luijendijk et al., 2003). Our data
oncontrastingchangesofhigh-frequencyauditorysensitivity in
the different Foxp2mouse lines calls for further studies of these
mutants, aiming to find the anatomical and/or physiological
bases of the observed changes.Beyond the sensitivity differences noted above, S321X
heterozygotes did not show any systematic modifications in
ABR parameters as compared to control littermates. In
contrast, we observed multiple differences for R552H hetero-
zygotes not only for thresholds, but also for wave amplitudes
and latencies. In particular, the R552H heterozygotes had a
tendency across all tested frequencies to smaller peak
amplitudes (significant for peaks I and IV, Fig. 4) and longer
peak latencies (significant for peaks I, III, IV, Fig. 6) compared
to their WT littermates. Since peaks of ABR waves represent
the sum of synchronously occurring postsynaptic potentials
at centers of the auditory pathway (Maurer et al., 1982; Parham
et al., 2001), these deviations suggest that the R552H hetero-
zygotes might have impaired synchronization of synaptic
transmission along auditory pathways starting with the
synapses between the cochlear hair cells and the auditory
nerve fibers. A slight desynchronization in the information
transfer through many channels automatically leads to
smaller amplitudes and longer latencies of the summed
postsynaptic potentials. The mechanism responsible for the
desynchronization has to be clarified in further tests.
Our distinct phenotypic findings for S321X and R552H lines
could relate to the differing nature of the mutations. Previous
studies have shown that the S321X nonsense mutation yields
a lack of Foxp2 protein and is effectively a null allele (Groszer
et al., 2008). S321X heterozygotes show a simple reduced
dosage of functional Foxp2 protein (around half the levels of
wildtypes); this is also likely to apply to human heterozygotes
carrying the R328X mutation (MacDermot et al., 2005). In con-
trast, rather than yielding absence of Foxp2 protein product,
the mouse R552H missense mutation (and its human equiva-
lent FOXP2-R553H) leads to stable expression of a full-length
mutant protein carrying an amino-acid substitution in its
DNA-binding domain, one which disrupts its function as a
transcription factor (Vernes et al., 2006). Therefore, although
R552H heterozygotes do indeed show a reduced dosage of
functional Foxp2 protein, there could also be further effects
mediated by the presence of the dysfunctional R552H form of
the protein. For example, Foxp2 proteins are known to act as
dimers (two molecules bound together), and it is possible that
mutant R552H protein might bind to wildtype protein, to have
consequences beyond a straightforward loss of function
(Vernes et al., 2006). Despite these potential mechanistic
differences, it should be stressed that in humans the R328X
and R553H mutations each lead to speech and language dis-
order, regardless of mutation type. We did not find any
consistent alterations in auditory processing that were com-
mon to the heterozygous S321X and R552H mouse mutants.
Thus, our findings would argue against the idea that FOXP2-
related speech and language disorder is purely secondary to
auditory processing deficits, and they require a more complex
interpretation.
Overall, these results illustrate the value of studying an
allelic series of mouse models carrying distinct aetiological
mutations in the same gene. We observed in vivo differences
in the impacts of distinct Foxp2 mutations on ABR measures,
which are interesting in light of different behaviours of mu-
tant products reported in previous cell-based studies (Vernes
et al., 2006). In addition, our findings add to the described
deficits in motor-skill learning and synaptic plasticity ob-
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important to be cautious when extrapolating from mouse
studies to consideration of human disorder, particularly in
relation to speech and language impairments (Fisher and
Scharff, 2009); for example, the differences in high-frequency
sensitivity we observed are in a range (when appropriately
transposed to the human situation) that is unlikely to have
relevance for speech perception (Ehret and Kurt, in press).
Nevertheless, the alterations of other ABR parameters in the
R552H mice raise the intriguing possibility that humans with
certain types of heterozygous FOXP2 mutations may show
alterations in auditory processing which potentially impact on
orofacial motor-skill learning and individual strategies for
speech therapy. Future studies of human cases are warranted
in order to assess this hypothesis.4. Experimental procedures
4.1. Animals
Generation and initial characterization of the Foxp2 mouse
mutants used in this study were previously described by
Groszer et al. (2008). Animals tested were heterozygous for
either the R552H or the S321X point mutation. Mutants were
backcrossed onto a C3H/HeN genetic background prior to
carrying out the phenotypic investigations described below.
Comparisons were made to wildtype (WT) littermate controls,
also on a C3H/HeN background. All animals were tested when
they were between 50 and 61 days old. In total, data were
obtained from 6 heterozygous R552H animals and 8 C3H/HeN
WT matched littermates, as well as from 7 heterozygous
S321X animals and 8 C3H/HeN WT matched littermates,
including both sexes. The experiments were carried out in
accordance with the European Communities Council Directive
(86/609/EEC) and were approved by the appropriate authority
(Regierungspräsidium Tübingen, Germany).
4.2. ABR measurements
ABRs to pure tones (2–45.25 kHz, 2 steps/octave) were recorded
in anesthetized animals in a sound attenuating chamber (IAC,
Industrial Acoustics Company). Anesthesia was performed by
intraperitoneal injection of a mixture of 100 mg/kg ketamin
hydrochloride (Ketavet 100, Pharmacia), 15 mg/kg xylazin
hydrochloride (Rompun 290, Bayer) and 0.5 mg/kg atropin
sulfate. Supplemental doses of anesthetics were given sub-
cutaneously as needed to keep the animals motionless during
the recording sessions. During recording, the animals were
placed on a feedback controlled heating pad for keeping their
body temperature constant at 37 °C.
Generation of acoustic stimuli and recording of evoked
potentials were performed using a Multi IO Card (National
Instruments, E-6052). Tone bursts (12 ms duration, 1 ms rise
and fall time, cosine-shaped) were delivered free-field at a rate
of 3/s through a dynamic speaker (Beyer DT911). Sound
pressure levels (SPLs) were measured and calibrated at the
animal's ear with a 6.35 mm probe microphone (Brüel & Kjaer
4135, Naerum, Denmark) and a measuring amplifier (Brüel &
Kjaer 2610). The synthesized tones were adjusted in level togenerate a flat ±6 dB sound field at the animal's ear in the
frequency range tested. Distortion products were at least 25 dB
below the tone levels at the highest levels (100 dB) used. To
record bioelectrical potentials, subdermal silver wire electro-
des (diameter 0.25 mm, Goodfellow) were inserted at the
vertex (reference), ventrolateral to the left ear (active) and
dorso-sacrum at the back of the animal (ground). After
amplification (100 dB) and bandpass filtering (200 Hz to
5 kHz), electrical signals were averaged over 256 tone burst
repetitions. The custom made software included an artifact
rejection code (all waveforms with a peak to peak amplitude
exceeding a defined voltage were rejected) to eliminate heart
beat andmuscle activity. The stimulus intensities used ranged
from 20 to 100 dB SPL (5 dB steps).
4.3. Data analysis
The ABR hearing threshold was determined as the lowest SPL
that produced the characteristic waveform of the ABR poten-
tials visually distinct from the noise level (Knipper et al., 2000).
Threshold values of ABRs were compared between hetero-
zygous mutants and WT littermates for statistically signifi-
cant differences by means of Student's two-tailed t-test
(⁎P<0.05, ⁎⁎P<0.01, ⁎⁎⁎P<0.001) and arranged across frequencies
to obtain audiograms for each animal group. To further
characterize ABR responses we analyzed peak latencies and
peak-to-trough amplitudes for all five ABR peaks (I to V). We
then tested for differences between heterozygotes and WT
animals with Student's two-tailed t-test (⁎P<0.05, ⁎⁎P<0.01,
⁎⁎⁎P<0.001). From average ABR waveforms, differences
between heterozygotes and WTs (value of heterozygote
minus value of WT) were calculated for peak amplitudes and
peak latencies at each frequency tested. These differences
were then averaged across all stimulation frequencies and
tested with a one sample t-test against the expected value of
zero difference (⁎P<0.05, ⁎⁎P<0.01, ⁎⁎⁎P<0.01).Acknowledgements
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